GNOM Fees and Costs — Global X Genomics & Biotechnology ETF
Data updated: 2026-07-29
The net expense ratio is 0.50%. There are no sales loads or redemption fees. In fiscal 2025 the fund paid $12K in broker commissions, 0.0216% of average net assets, and portfolio turnover was 34%.
GNOM Fees and Expenses
Annual operating expenses and sales charges of GNOM. Prospectus, as of April 1, 2026.
| Annual operating expenses | |
|---|---|
| Management fee | 0.50% |
| 12b-1 fee | 0.00% |
| Other expenses | 0.00% |
| Gross expense ratio | 0.50% |
| Fee waiver | — |
| Net expense ratio | 0.50% |
| Sales charges | |
|---|---|
| Max front load | — |
| Max deferred load | — |
| Redemption fee | — |
| Expense limitation in place (N-CEN) | No |
| Fees waived or reduced during the year | No |
| Waived fees subject to recoupment | No |
GNOM Costs Over Time
On $10,000 invested in GNOM, assuming 5% a year before costs, total costs come to $329 over 5 years, cutting the return by 0.55% a year. Illustration, not a forecast: it assumes today's net expense ratio throughout (a fee waiver may end).
| $10,000 invested | Sell after 1 year | Sell after 3 years | Sell after 5 years |
|---|---|---|---|
| Value before costs | $10,500 | $11,576 | $12,763 |
| Fund expenses (net expense ratio 0.50%) | $52 | $165 | $287 |
| Trading costs (broker commissions) | $2 | $7 | $12 |
| Lost growth on money paid in costs | $0 | $8 | $30 |
| Total costs | $55 | $180 | $329 |
| Value after costs | $10,445 | $11,396 | $12,433 |
| Impact on return, per year | 0.55% | 0.55% | 0.55% |
GNOM Trading Costs
Brokerage costs reported on SEC Form N-CEN for the fiscal year ending November 30, 2025.
- Explicit cost rate (commissions ÷ average net assets): 0.0216%
- Total broker commissions: $12K
- Bought from dealers (principal trades, not a cost): —
- Portfolio turnover (prospectus): 34%
- Securities on loan, average value: $4.0M
- Net income from securities lending: $87K (0.163% of average net assets)
GNOM Agency Brokers
Commissions paid.
| Broker | Amount | Share |
|---|---|---|
| BAIRD, ROBERT W., & CO., INCORPORATED | $7K | 61.60% |
| MIZUHO SECURITIES USA INC | $4K | 35.61% |
| CITIGROUP | $323 | 2.79% |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.